Literature DB >> 3898083

Evidence that major histocompatibility complex restriction of foreign transplantation antigens occurs when tolerance is induced in neonatal mice and rats.

L Desquenne-Clark, H Kimura, W K Silvers.   

Abstract

Studies on the survival of skin-specific antigen (Skn)-incompatible skin grafts in mice rendered tolerant at birth with major histocompatibility complex (MHC)-incompatible lymph node and spleen or bone marrow cells, as well as studies concerned with the survival of third-party skin grafts in rats rendered tolerant at birth with MHC-incompatible bone marrow cells, indicate that MHC restriction of foreign transplantation antigens occurs when tolerance is induced. Thus, evidence is presented that animals rendered tolerant with MHC-incompatible bone marrow cells depleted of mature T lymphocytes will accept any graft that is homozygous for the bone marrow donor's foreign MHC. Evidence has also been obtained that continuous exposure to foreign transplantation antigens in association with an MHC different from that of the graft may induce unresponsiveness to the same antigens in association with the MHC of the graft.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898083      PMCID: PMC391033          DOI: 10.1073/pnas.82.18.6265

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Quantitative studies on the induction of tolerance of skin homografts and on runt disease in neonatal rats.

Authors:  R E BILLINGHAM; W K SILVERS; D STEINMULLER
Journal:  J Natl Cancer Inst       Date:  1962-02       Impact factor: 13.506

2.  Tolerance of Sk-incompatible skin grafts.

Authors:  E A Boyse; E A Carswell; M P Scheid; L J Old
Journal:  Nature       Date:  1973-08-17       Impact factor: 49.962

3.  Contributions of the rat to the immunobiology of tissue transplantation.

Authors:  W K Silvers; R E Billingham
Journal:  Transplant Proc       Date:  1970-03       Impact factor: 1.066

4.  Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier.

Authors:  E M Lance; E A Boyse; S Cooper; E A Carswell
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

5.  Mixed lymphocyte reactions and tissue transplantation tolerance.

Authors:  W K Silvers; D M Lubaroff; D B Wilson; D Fox
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

6.  Evidence from in vitro studies that tolerance to self antigens is MHC-restricted.

Authors:  H G Rammensee; M J Bevan
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

7.  Major-histocompatibility-complex-restricted male skin graft rejection responses in rats.

Authors:  M Miyamoto; T Sano; K Suzuki; T Fukumoto
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

8.  The behavior of skin grafts incompatible with respect to skin alloantigens on mice rendered tolerant at birth with lymphoid cells.

Authors:  W K Silvers; S S Wachtel; T W Poole
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice.

Authors:  J A Donohoe; L Andrus; K M Bowen; C Simeonovic; S J Prowse; K J Lafferty
Journal:  Transplantation       Date:  1983-01       Impact factor: 4.939

10.  Lymph node cells: their differential capacity to induce tolerance of heart and skin homografts in rats.

Authors:  C F Barker; D M Lubaroff; W K Silvers
Journal:  Science       Date:  1971-06-04       Impact factor: 47.728

View more
  2 in total

1.  Major histocompatibility complex (MHC) restriction of foreign transplantation antigens in rats rendered tolerant at birth.

Authors:  H Kimura; L Desquenne-Clark; M Miyamoto; W K Silvers
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

2.  Alloantigen persistence in induction and maintenance of transplantation tolerance.

Authors:  S Morecki; B Leshem; A Eid; S Slavin
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.